Yacktman Asset Management's Q3 2025 13F portfolio value declined to $7.26B, with 70 holdings and ~9% cash. Top five positions ...

A £30 billion takeover shakes up the consumer health sector as Kimberly-Clark, the maker of Huggies nappies, prepares to ...

The Kimberly-Clark/Kenvue transaction is one of the worst-received major merger deals in recent years. Investors wondered why ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...

In other news, Apple suppliers Qorvo and Skyworks plan to combine and metal card maker Composecure offers a bid for Husky ...

A number of prominent hedge funds are likely applauding Monday’s news that Kimberly-Clark Corp. has agreed to acquire Kenvue ...

AM ET, the S&P 500 gained 10.83 points, or 0.16%, the Nasdaq Composite gained 119.50 points, or 0.51%, and the Dow Jones ...

Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears ...

Evercore also said Kimberly’s move expands its footprint into two stable, cash-generative global categories, personal hygiene and consumer health, that have high barriers to entry and rational pricing ...

Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s ...

Despite a headline beat and decent revenue forecast, the poor reaction to the update from AI and data analytics darling ...